{"accident": 9.12, "ankle fracture": 6.45, "ataxia": 2.25, "balance disorder": 10.69, "bladder disorder": 22.35, "blood test abnormal": 6.63, "constipation": 2.45, "coronavirus infection": 19.67, "cystitis": 16.75, "cystitis noninfective": 22.39, "drug ineffective": 2.95, "dysstasia": 6.62, "epilepsy": 7.18, "facial pain": 5.88, "fall": 5.58, "gait disturbance": 15.62, "gait inability": 11.69, "gastrointestinal disorder": 3.43, "general physical health deterioration": 3.08, "generalised tonic-clonic seizure": 4.58, "hip fracture": 6.42, "insomnia": 4.38, "intentional product misuse": 3.48, "intentional underdose": 18.5, "loss of control of legs": 37.09, "loss of therapeutic response": 21.2, "lower limb fracture": 5.16, "lymphocyte count decreased": 7.55, "lymphopenia": 7.7, "mental disorder": 3.03, "mobility decreased": 15.68, "motor dysfunction": 26.15, "multiple sclerosis": 43.99, "multiple sclerosis relapse": 45.49, "muscle spasms": 2.88, "muscle spasticity": 49.69, "muscle tightness": 5.4, "muscular weakness": 3.39, "musculoskeletal disorder": 24.71, "nasopharyngitis": 2.93, "nephrolithiasis": 3.25, "neuralgia": 2.36, "poor quality sleep": 14.46, "prescribed underdose": 17.64, "primary progressive multiple sclerosis": 382.67, "product dose omission in error": 28.32, "product dose omission issue": 6.12, "product residue present": 6.99, "restless legs syndrome": 3.26, "secondary progressive multiple sclerosis": 278.61, "seizure": 2.43, "sensory disturbance": 2.33, "sleep disorder": 3.71, "status epilepticus": 11.34, "temperature intolerance": 9.21, "therapeutic product effect decreased": 7.53, "therapy non-responder": 21.04, "trigeminal neuralgia": 26.78, "underdose": 25.52, "urinary incontinence": 3.87, "urinary tract infection": 8.62, "urinary tract obstruction": 29.55, "vitamin d deficiency": 8.02}